TY - JOUR
T1 - Mast cell activation test in the diagnosis of allergic disease and anaphylaxis
AU - Bahri, Rajia
AU - Custovic, Adnan
AU - Korosec, Peter
AU - Tsoumani, Marina
AU - Barron, Martin
AU - Wu, Jiakai
AU - Sayers, Rebekah
AU - Weimann, Alf
AU - Ruiz-Garcia, Monica
AU - Patel, Nandinee
AU - Robb, Abigail
AU - Shamji, M. H.
AU - Fontanella, Sara
AU - Silar, Mira
AU - Mills, ENC
AU - Simpson, Angela
AU - Turner, Paul J
AU - Bulfone-Paus, Silvia
N1 - Publisher Copyright:
© 2018 The Authors
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2018/3/5
Y1 - 2018/3/5
N2 - Background: Food allergy is an increasing public health issue and the most common cause of life-threatening anaphylactic reactions. Conventional allergy tests assess for the presence of allergen-specific IgE, significantly overestimating the rate of true clinical allergy and resulting in overdiagnosis and adverse effect on health-related quality of life. Objective: To undertake initial validation and assessment of a novel diagnostic tool, we used the mast cell activation test (MAT). Methods: Primary human blood-derived mast cells (MCs) were generated from peripheral blood precursors, sensitized with patients’ sera, and then incubated with allergen. MC degranulation was assessed by means of flow cytometry and mediator release. We compared the diagnostic performance of MATs with that of existing diagnostic tools to assess in a cohort of peanut-sensitized subjects undergoing double-blind, placebo-controlled challenge. Results: Human blood-derived MCs sensitized with sera from patients with peanut, grass pollen, and Hymenoptera (wasp venom) allergy demonstrated allergen-specific and dose-dependent degranulation, as determined based on both expression of surface activation markers (CD63 and CD107a) and functional assays (prostaglandin D
2 and β-hexosaminidase release). In this cohort of peanut-sensitized subjects, the MAT was found to have superior discrimination performance compared with other testing modalities, including component-resolved diagnostics and basophil activation tests. Using functional principle component analysis, we identified 5 clusters or patterns of reactivity in the resulting dose-response curves, which at preliminary analysis corresponded to the reaction phenotypes seen at challenge. Conclusion: The MAT is a robust tool that can confer superior diagnostic performance compared with existing allergy diagnostics and might be useful to explore differences in effector cell function between basophils and MCs during allergic reactions.
AB - Background: Food allergy is an increasing public health issue and the most common cause of life-threatening anaphylactic reactions. Conventional allergy tests assess for the presence of allergen-specific IgE, significantly overestimating the rate of true clinical allergy and resulting in overdiagnosis and adverse effect on health-related quality of life. Objective: To undertake initial validation and assessment of a novel diagnostic tool, we used the mast cell activation test (MAT). Methods: Primary human blood-derived mast cells (MCs) were generated from peripheral blood precursors, sensitized with patients’ sera, and then incubated with allergen. MC degranulation was assessed by means of flow cytometry and mediator release. We compared the diagnostic performance of MATs with that of existing diagnostic tools to assess in a cohort of peanut-sensitized subjects undergoing double-blind, placebo-controlled challenge. Results: Human blood-derived MCs sensitized with sera from patients with peanut, grass pollen, and Hymenoptera (wasp venom) allergy demonstrated allergen-specific and dose-dependent degranulation, as determined based on both expression of surface activation markers (CD63 and CD107a) and functional assays (prostaglandin D
2 and β-hexosaminidase release). In this cohort of peanut-sensitized subjects, the MAT was found to have superior discrimination performance compared with other testing modalities, including component-resolved diagnostics and basophil activation tests. Using functional principle component analysis, we identified 5 clusters or patterns of reactivity in the resulting dose-response curves, which at preliminary analysis corresponded to the reaction phenotypes seen at challenge. Conclusion: The MAT is a robust tool that can confer superior diagnostic performance compared with existing allergy diagnostics and might be useful to explore differences in effector cell function between basophils and MCs during allergic reactions.
KW - Anaphylaxis
KW - basophil activation test
KW - diagnosis
KW - food allergy
KW - mast cell activation test
KW - mast cells
KW - peanut allergy
UR - http://www.scopus.com/inward/record.url?scp=85044507900&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2018.01.043
DO - 10.1016/j.jaci.2018.01.043
M3 - Article
C2 - 29518421
SN - 0091-6749
VL - 142
SP - 485-496.e16
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 2
ER -